C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation

Two consecutive multi-center phase II trials were designed to prove the hypothesis, whether therapeutic modeling of tumor-associated inflammatory processes could result in improved tumor response. Therapy in both trials consisted of low-dose capecitabine 1g/m2 twice daily p.o. for 14 days, every 3 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Reichle, Albrecht, Grassinger, Jochen, Bross, Klaus, Wilke, Jochen, Suedhoff, Thomas, Walter, Bernhard, Wieland, Wolf-Ferdinand, Berand, Anna, Andreesen, Reinhard
Formato: Texto
Lenguaje:English
Publicado: Libertas Academica 2007
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716790/
https://www.ncbi.nlm.nih.gov/pubmed/19690640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716790/
https://www.ncbi.nlm.nih.gov/pubmed/19690640

Ejemplares similares